Topics › Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology
Amyloidosis: Diagnosis, Treatment, Outcomes Sign in to save
Papers per year
Papers 70
Open in paper search →-
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis2021 New England Journal of Medicine article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access cited by 1 patent
Efstathios Kastritis, Giovanni O. Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, Hans Chulhee Lee, +43 more
701citations -
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA2020 Blood article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Giovanni O. Palladini, Efstathios Kastritis, Mathew S. Maurer, Jeffrey A. Zonder, Monique C. Minnema, Ashutosh D. Wechalekar, +14 more
212citations -
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update2022 Orphanet Journal of Rare Diseases article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access cited by 1 patent
Angela A. Dispenzieri, Teresa Coelho, Isabel M. Conceição, Márcia Waddington‐Cruz, Jonas Wixner, Arnt V. Kristen, +77 more
93citations -
Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis among 1523 US adults diagnosed between 2001 and 20192021 European Journal Of Haematology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes cited by 2 patents
Laura Hester, Dina Gifkins, Kevin M. Bellew, JESSICA T. VERMEULEN, Jordan Mark Schecter, John T. Strony, +2 more
53citations -
Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis2020 Journal of Neurochemistry article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access cited by 1 patent
Maike Franziska Dohrn, Sandra Michaela Ihne-Schubert, Ute Hegenbart, Jessica Medina, Stephan L. Zuchner, Teresa Coelho, +1 more
39citations -
Prognostic Implications of Right Ventricular Systolic Dysfunction in Cardiac Amyloidosis2022 The American Journal of Cardiology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Catherina Tjahjadi, Federico Fortuni, Jan Stassen, Philippe Debonnaire, Rodolfo de Paula Lustosa, Nina Ajmone Marsan, +2 more
38citations -
Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literature2020 Journal of Neurology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Maike Franziska Dohrn, Michaela Auer‐Grumbach, Ralf Baron, Frank Birklein, Fabiola Escolano‐Lozano, Christian Geber, +11 more
36citations -
Are we creating a new phenotype? Physiological barriers and ethical considerations in the treatment of hereditary transthyretin-amyloidosis2021 Neurological Research and Practice article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Maike Franziska Dohrn, Jessica Medina, Karmele Olaciregui Dague, Ernst Hund
25citations -
Echocardiographic predictors of presence of cardiac amyloidosis in aortic stenosis2022 European Heart Journal - Cardiovascular Imaging article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Vikash Jaiswal, Song Peng Ang, Jia Ee Chia, Eman Muhammad Abdelazem, Akash Jaiswal, Monodeep Biswas, +4 more
24citations -
Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis2022 JACC CardioOncology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Monique C. Minnema, Angela A. Dispenzieri, Giampaolo Merlini, Raymond L. Comenzo, Efstathios Kastritis, Ashutosh D. Wechalekar, +10 more
24citations -
Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study2023 Amyloid article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Shaji Kunnathu Kumar, Angela A. Dispenzieri, Divaya Bhutani, Morie Abraham Gertz, Ashutosh D. Wechalekar, Giovanni O. Palladini, +9 more
23citations -
Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay2023 Amyloid article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Teresa Coelho, Angela A. Dispenzieri, Martha A. Grogan, Isabel M. Conceição, Márcia Waddington‐Cruz, Arnt V. Kristen, +80 more
15citations -
Reduction in Absolute Involved Free Light Chain and Difference between Involved and Uninvolved Free Light Chain Is Associated with Prolonged Major Organ Deterioration Progression-Free Survival in Patients with Newly Diagnosed AL Amyloidosis Receiving Bortezomib, Cyclophosphamide, and Dexamethasone with or without Daratumumab: Results from Andromeda2020 Blood article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Raymond L. Comenzo, Efstathios Kastritis, Giovanni O. Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, +27 more
15citations -
Subcutaneous Daratumumab (DARA) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Overall Survival and Final Major Organ Deterioration Progression-Free Survival Results from the Phase 3 Andromeda Study2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Efstathios Kastritis, Giovanni O. Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, Hans Chulhee Lee, +24 more
15citations -
Left Ventricular Myocardial Work to Differentiate Cardiac Amyloidosis From Hypertrophic Cardiomyopathy2022 Journal of the American Society of Echocardiography article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Jan Stassen, Catherina Tjahjadi, Robert Daniel Adam, Philippe Debonnaire, Mathias Claeys, Bogdan Alexandru Popescu, +4 more
14citations -
Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis2023 Hematology review Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Efstathios Kastritis, Arpit Misra, Laura Gurskyte, Florint Kroi, Andre Verhoek, JESSICA T. VERMEULEN, +4 more
13citations -
Outcomes in patients with cardiac amyloidosis undergoing heart transplantation: the eurotransplant experience2023 The Journal of Heart and Lung Transplantation article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Martin J. Kraus, Jacqueline M. Smits, Anna Lassia Meyer, Agita Strēlniece, Arne van Kins, Udo Boeken, +14 more
13citations -
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA2023 Annals of Hematology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kım, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, +16 more
13citations -
Subcutaneous Daratumumab with Bortezomib, Cyclophosphamide, and Dexamethasone in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: 18-Month Analysis of the Phase 3 ANDROMEDA Study2021 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Raymond L. Comenzo, Giovanni O. Palladini, Efstathios Kastritis, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, +24 more
12citations -
Population Pharmacokinetics and Exposure‐Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light‐Chain Amyloidosis2021 The Journal of Clinical Pharmacology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Man Luo, Peijuan Zhu, Ivo P. Nnane, Yuan Lu Xiong, Giampaolo Merlini, Raymond L. Comenzo, +9 more
10citations
Most active Aachen authors
-
JESSICA T. VERMEULEN 10,466 citations overall18 papers
-
Nina Ajmone Marsan 30,850 citations overall15 papers
-
Jeroen Joost Bax 289,528 citations overall13 papers
-
Maike Franziska Dohrn 995 citations overall9 papers
-
Jan Stassen 1,147 citations overall8 papers
-
Brenda J. Tromp 1,737 citations overall7 papers
-
Madelien Veronique Regeer 1,049 citations overall7 papers
-
Catherina Tjahjadi 152 citations overall6 papers
-
Victoria Delgado 286,174 citations overall4 papers
-
Dorien Laenens 225 citations overall4 papers
-
Xin Li 1,602 citations overall3 papers
-
N Ajmone Marsan 3 citations overall3 papers
-
Pieter van der Bijl 6,269 citations overall2 papers
-
Luuk A. Gras 5,079 citations overall2 papers
-
Philippe Debonnaire 4,071 citations overall2 papers